oxomemazine
Small moleculeexperimental
Oxomemazine is an antihistamine and anticholinergic of the phenothiazine chemical class for the treatment of cough. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Feb 1, 2013 (NCT01257243)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Histamine H1 receptorINHIBITOR
HRH1 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CC(CN(C)C)CN1c2ccccc2S(=O)(=O)c2ccccc21- Mol. weight
- 330.45 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaOxomemazine ↗
- ChEMBLCHEMBL2104734 ↗
Also known as
- doxergan
- dysedon
- oxomemazin
- oxomemazine
- oxomemazine
- oxomemazine
- oxomemazine
- oxomemazine
- oxomemazine
- oxomemazine
- rp-6847
- rp-6847
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01257243 | Phase 3 | Feb 1, 2013 | EMS S/A |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| EMS S/A | For profit | 1 | 1 | 1 | 2013 |
1 organizations
Page 1 / 1